Palo Alto Investors LP Gossamer Bio, Inc. Transaction History
Palo Alto Investors LP
- $790 Million
- Q2 2024
A detailed history of Palo Alto Investors LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 6,277,093 shares of GOSS stock, worth $5.65 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
6,277,093
Previous 6,391,775
1.79%
Holding current value
$5.65 Million
Previous $7.54 Million
25.1%
% of portfolio
0.72%
Previous 0.88%
Shares
13 transactions
Others Institutions Holding GOSS
# of Institutions
103Shares Held
175MCall Options Held
453KPut Options Held
543K-
Nea Management Company, LLC Timonium, MD18.1MShares$16.3 Million1.54% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$12 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$10.6 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.27 Million1.91% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$7.25 Million4.25% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $84.6M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...